California Nanotechnologies Corp Stock Target Price
| CANOF Stock | USD 0.28 0.01 3.70% |
As of the 27th of January, California Nanotechnologies shows the Risk Adjusted Performance of 0.0135, downside deviation of 7.1, and Mean Deviation of 2.39. California Nanotechnologies technical analysis gives you the methodology to make use of historical prices and volume patterns to determine a pattern that approximates the direction of the firm's future prices. Please confirm California Nanotechnologies information ratio, as well as the relationship between the value at risk and expected short fall to decide if California Nanotechnologies is priced correctly, providing market reflects its regular price of 0.28 per share. As California Nanotechnologies appears to be a penny stock we also recommend to validate its total risk alpha numbers.
California Nanotechnologies' financial statements offer valuable quarterly and annual insights to potential investors, highlighting the company's current and historical financial position, overall management performance, and changes in financial standing over time. Key fundamentals influencing California Nanotechnologies' valuation are provided below:California Nanotechnologies Corp does not presently have any fundamental signals for analysis. This module does not cover all equities due to inconsistencies in global equity categorizations. Continue to Equity Screeners to view more equity screening tools. California |
Did you try this?
Run Money Managers Now
Money ManagersScreen money managers from public funds and ETFs managed around the world |
| All Next | Launch Module |
California Fundamentals
| Return On Asset | 0.35 | |||
| Profit Margin | 0.23 % | |||
| Operating Margin | 0.28 % | |||
| Current Valuation | 3.75 M | |||
| Shares Outstanding | 31.8 M | |||
| Shares Owned By Insiders | 37.21 % | |||
| Price To Earning | 6.75 X | |||
| Price To Sales | 1.88 X | |||
| Revenue | 1.08 M | |||
| Gross Profit | 757.32 K | |||
| EBITDA | 404.99 K | |||
| Net Income | 200.6 K | |||
| Cash And Equivalents | 175.32 K | |||
| Cash Per Share | 0.01 X | |||
| Total Debt | 1.81 M | |||
| Current Ratio | 1.33 X | |||
| Book Value Per Share | (0.03) X | |||
| Cash Flow From Operations | 143.74 K | |||
| Earnings Per Share | 0.01 X | |||
| Beta | 1.63 | |||
| Market Capitalization | 3.07 M | |||
| Total Asset | 959.04 K | |||
| Z Score | 1.6 | |||
| Net Asset | 959.04 K |
About California Nanotechnologies Fundamental Analysis
The Macroaxis Fundamental Analysis modules help investors analyze California Nanotechnologies Corp's financials across various querterly and yearly statements, indicators and fundamental ratios. We help investors to determine the real value of California Nanotechnologies using virtually all public information available. We use both quantitative as well as qualitative analysis to arrive at the intrinsic value of California Nanotechnologies Corp based on its fundamental data. In general, a quantitative approach, as applied to this company, focuses on analyzing financial statements comparatively, whereas a qaualitative method uses data that is important to a company's growth but cannot be measured and presented in a numerical way.
Please read more on our fundamental analysis page.
Currently Active Assets on Macroaxis
Other Information on Investing in California Pink Sheet
California Nanotechnologies financial ratios help investors to determine whether California Pink Sheet is cheap or expensive when compared to a particular measure, such as profits or enterprise value. In other words, they help investors to determine the cost of investment in California with respect to the benefits of owning California Nanotechnologies security.